BSE filing, NSE: SHREEPUSHK. Summary written from the filing by ALFA Finder's alert engine.
Shree Pushkar Chemicals & Fertilisers Ltd: key numbers
- Share price
- ₹574.55
- Market cap
- ₹1,858 Cr
- Revenue (annual)
- ₹976.6 Cr
- Net profit (annual)
- ₹70.10 Cr
- P/E (TTM)
- 20.7×Sector 34.1×
- Promoter holding
- 69.45%+0.09% QoQ
- FII holding
- 0.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Pushkar Chemicals & Fertilisers Ltd
All →Shree Pushkar Chemicals & Fertilisers Preferential Issue
Shree Pushkar called an EGM to approve Rs 45 Crore promoter warrants at Rs 526.90 each. Warrants convert into equity within 18 months.
- Value
- ₹45.00 Cr
Shree Pushkar Chemicals & Fertilisers Earnings Call Transcript: Key Takeaways
Q2 revenue ₹403.5 Cr (+58.2%) and EBITDA ₹49.2 Cr (+87.7%) look price-led. Management was evasive on sustainability, inventory gains, and Unit 6 timing.
Shree Pushkar Chemicals & Fertilisers Other Announcement
Shree Pushkar Chemicals reported no deviation in using preferential warrant funds for the quarter ended 30 September 2026. Rs.7.50 crore subscription money has been received so far.
Shree Pushkar Chemicals & Fertilisers Capital Structure Change
Shree Pushkar Chemicals' board approved reissue of forfeited shares and fund raising. Authorised capital rises to 34 million shares, subject to a 2 December 2026 vote.
Shree Pushkar Chemicals & Fertilisers Fund Raise of ₹45 Cr
Shree Pushkar's board approved a preferential issue of 854,060 convertible warrants to Punit Makharia. The issue would raise about Rs.45.00 Crore at Rs.527 per warrant.
- Value
- ₹45.00 Cr
Shree Pushkar Chemicals & Fertilisers Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 403.5 Cr (+58.2% YoY), EBITDA Rs 49.2 Cr (12.2% margin), PAT Rs 35.7 Cr (+96.1%). H1 revenue Rs 683.6 Cr (+34.1%). Growth driven by capacity additions.
Other convertible warrants announcements
All →Flywings Simulator Training Centre Convertible Warrants
Flywings seeks approval to issue up to 29.88 lakh warrants at Rs.245, aggregating Rs.73.20 Crore. Includes promoter Rupal Mandavia; EGM is on 27 November 2026.
- Value
- ₹73.20 Cr
- Execution
- Warrants exercisable within 18 months from the date of allotment
Godavari Drugs Convertible Warrants
Godavari Drugs allotted 7,86,690 equity shares to promoter-category allottees on conversion of warrants. The balance consideration of Rs 5.25 Crore was received at an issue price of Rs 89.
- Value
- ₹5.25 Cr
Sahana System Convertible Warrants
Sahana System has issued a corrigendum to its postal ballot notice on warrant issuance. Warrants total ₹125 Crore at ₹950 each to identified allottees.
- Value
- ₹125.0 Cr
- Execution
- Warrant conversion within eighteen (18) months
Dev Labtech Venture Convertible Warrants
Dev Labtech Venture approved issuance of up to 1.37 crore convertible warrants at Rs.13 each to promoters and non-promoters on preferential basis. The issue aggregates Rs.17.81 Crore for cash.
- Value
- ₹17.81 Cr
Bajaj Finance Convertible Warrants
Bajaj Finance's special committee meets on 10 November 2026 to approve the price for warrants issued to the promoter. This is a pricing step of a promoter warrant issue.
Dev Labtech Venture Convertible Warrants
Dev Labtech Venture's EGM passed an authorised capital increase and a convertible warrant issue, both with 100% votes in favour. Promoters did not vote on the warrants.